Appropriate use |
Serious infections caused by b-lactam-resistant Gram-positive microorganisms; |
Infection caused by Gram-positive organisms in patients allergic to b-lactam antimicrobials; |
Antibiotics treatment for colitis when there is a problem with metronidazole use or imminent life risk; |
Surgical prophylaxis, with prosthesis implant, in institutions with high rates of oxacillin-resistant Gram-positive infections; |
Neutropenics with extensive mucosite, infection related to venous catheters, previous prophylaxis with fluorquinolone, hypotension or sepsis. |
Inappropriate use: |
Routine surgical prophylaxis; |
Febrile neutropenia that does not present isolation of oxacillin-resistant Gram-positive bacteria; |
Treatment of a single blood culture for oxacillin-resistant Staphylococcus, coagulase-negative, if another culture collected simultaneously was sterile; |
Empirical use, continuous, in patients whose cultures are negative for Gram-positive bacteria; |
Presence of catheter and fever; |
Decontamination of the gastrointestinal tract; |
Prophylaxis for low birth weight infants; |
Primary treatment of colitis by antibiotics; |
Colonization by oxacillin-resistant Gram-positive bacteria; |
Prophylaxis for patients in continuous peritoneal dialysis or hemodialysis; |
Convenience treatment of infections by b-lactam-sensitive Gram-positive in hemodialysis patients; |
Topical vancomycin use. |